Screener examples › Sectors & Themes
Healthcare services at fair valuations
Profitable healthcare operators outside speculative biotech.
“US healthcare services companies over $2B with forward P/E under 22, revenue growth above 8% and positive free cash flow”
Run this screen live and refine it in plain English (free, no sign-up).
US healthcare companies above $2B with forward P/E under 22, revenue growth over 8% and positive free cash flow.
Filters: Sector = Healthcare; Market cap > $2B; Forward P/E < 22; Revenue growth > 8%; Free cash flow > 0
Top matches on data as of November 6, 2026
| Symbol | Company | Industry | Market Cap (USD) | Fwd P/E | Rev Growth YoY | FCF (TTM) | FCF Margin | Price | Currency |
|---|---|---|---|---|---|---|---|---|---|
| BHC | Bausch Health Companies Inc. | Drug Manufacturers - Specialty & Generic | $3.1B | 1.87 | 34.0% | $1.8B | 16.5% | $8.18 | USD |
| SUPN | Supernus, Inc. | Drug Manufacturers - Specialty & Generic | $3.1B | 6.59 | 30.1% | $31.0M | 2.3% | $26.16 | USD |
| UHS | Universal Health Services, Inc. | Medical - Care Facilities | $11.5B | 8.43 | 8.0% | $1.1B | 6.1% | $195.50 | USD |
| SNY | Sanofi | Drug Manufacturers - General | $112.0B | 9.25 | 11.0% | $13.2B | 23.3% | $47.04 | USD |
| BMRN | BioMarin Pharmaceutical Inc. | Biotechnology | $10.8B | 9.35 | 18.1% | $557.9M | 15.3% | $56.03 | USD |
| JAZZ | Jazz Pharmaceuticals plc | Biotechnology | $15.2B | 9.71 | 13.5% | $1.6B | 33.3% | $234.76 | USD |
| PFE | Pfizer Inc. | Drug Manufacturers - General | $167.5B | 10.12 | 8.3% | $11.8B | 18.5% | $29.39 | USD |
| HALO | Halozyme Therapeutics, Inc. | Biotechnology | $11.8B | 10.22 | 45.0% | $885.9M | 49.1% | $103.63 | USD |
| RPRX | Royalty Pharma plc | Medical - Pharmaceuticals | $30.0B | 11.73 | 11.4% | $3.0B | 113.1% | $67.30 | USD |
| SNN | Smith & Nephew plc | Medical - Devices | $13.2B | 13.17 | 9.7% | $1.4B | 11.0% | $31.15 | USD |
| OSCR | Oscar Health, Inc. | Medical - Healthcare Plans | $9.5B | 13.22 | 54.8% | $4.1B | 23.4% | $30.65 | USD |
| GMED | Globus Medical, Inc. | Medical - Devices | $9.5B | 13.32 | 13.4% | $756.6M | 24.1% | $71.05 | USD |
| REGN | Regeneron Pharmaceuticals, Inc. | Biotechnology | $92.0B | 13.41 | 18.6% | $3.6B | 21.2% | $904.35 | USD |
| BSX | Boston Scientific Corporation | Medical - Devices | $61.9B | 13.48 | 8.9% | $3.3B | 15.8% | $42.75 | USD |
| THC | Tenet Healthcare Corporation | Medical - Care Facilities | $22.7B | 13.63 | 9.3% | $3.3B | 14.6% | $283.33 | USD |
| AUPH | Aurinia Pharmaceuticals Inc. | Biotechnology | $2.2B | 14.55 | 21.0% | $175.5M | 54.6% | $16.46 | USD |
| AVAH | Aveanna Healthcare Holdings Inc. | Medical - Care Facilities | $2.9B | 14.82 | 19.5% | $165.8M | 6.4% | $13.25 | USD |
| ALNY | Alnylam Pharmaceuticals, Inc. | Biotechnology | $20.9B | 14.86 | 56.2% | $500.7M | 10.0% | $155.94 | USD |
| WAY | Waystar Holding Corp. | Medical - Healthcare Information Services | $5.4B | 15.34 | 21.4% | $264.1M | 20.9% | $28.35 | USD |
| NVST | Envista Holdings Corp | Medical - Instruments & Supplies | $4.0B | 15.36 | 9.8% | $226.2M | 7.9% | $25.17 | USD |
| INCY | Incyte Corporation | Biotechnology | $24.3B | 16.08 | 24.9% | $684.9M | 11.4% | $119.65 | USD |
| ADUS | Addus HomeCare Corporation | Medical - Care Facilities | $2.3B | 16.65 | 11.5% | $142.5M | 9.5% | $124.31 | USD |
| EXEL | Exelixis, Inc. | Biotechnology | $17.2B | 17.03 | 9.1% | $1.2B | 46.1% | $69.57 | USD |
| AMRX | Amneal Pharmaceuticals, Inc. | Drug Manufacturers - Specialty & Generic | $6.8B | 17.07 | 8.9% | $40.4M | 1.3% | $20.14 | USD |
| NBIX | Neurocrine Biosciences, Inc. | Biotechnology | $16.7B | 17.9 | 38.0% | $1.0B | 28.1% | $164.63 | USD |
25 matches. Research data, not investment advice.